You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The high-throughput and assay development agreement will focus on identifying and validating hits for an immune disease and cancer-related target.
Kinaxo’s phosphoproteomic tools will support targeted treatment development at Roche.
The German biotech plans to invest €3 million to €4 million in biomarker development over the next two years.
Christian Jurinke, Jeff Protentis, Jürgen Schumacher
In addition to biomarker discovery, Kinaxo's PhosphoScout technology will be used to assess the anti-cancer drug Nexavar's effects on cellular phosphorylation patterns.
Kinaxo Biotechnologies and Bayer Vital announced that they are collaborating to identify novel cancer treatment biomarkers.
The companies have extended one agreement and formed another focused on bringing an Ono compound towards clinical development.
Agilent Technologies, Bio-Rad, Bruker, Pressure BioScieces, Thermo Fisher Scientific, Pheonomenex, Kinaxo
Evotec will screen a target and develop assays for Biogen Idec.
Nature News reports on the US National Science Foundation's investigations of undisclosed foreign ties among researchers it funds.
Researchers have developed a set of 10 principles to guide how a list of all species on earth should be put together, the Guardian reports.
Wired reports on a new firm developing a gene writing approach for therapeutic genome changes.
In Nature this week: a method called cis-X combines whole-genome and transcriptome sequencing data to identify regulatory noncoding variants, and more.